Cargando…

Serious Neurological Adverse Events after Ivermectin—Do They Occur beyond the Indication of Onchocerciasis?

Serious neurological adverse events have been reported from large scale community-based ivermectin treatment campaigns against Onchocerciasis volvulus in Africa. The mechanism of these events has been debated in the literature, largely focusing on the role of concomitant infection with Loa loa versu...

Descripción completa

Detalles Bibliográficos
Autor principal:	Chandler, Rebecca E.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	The American Society of Tropical Medicine and Hygiene 2018
Materias:	Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5929173/ https://www.ncbi.nlm.nih.gov/pubmed/29210346 http://dx.doi.org/10.4269/ajtmh.17-0042

Ejemplares similares

Serious adverse events following treatment with ivermectin for onchocerciasis control: a review of reported cases
por: Twum-Danso, Nana AY
Publicado: (2003)

Clinical picture, epidemiology and outcome of Loa-associated serious adverse events related to mass ivermectin treatment of onchocerciasis in Cameroon
por: Boussinesq, Michel, et al.
Publicado: (2003)

Programmatic and Communication Issues in Relation to Serious Adverse Events Following Ivermectin Treatment in areas Co-endemic for Onchocerciasis and Loiasis
por: Haselow, Nancy J, et al.
Publicado: (2003)

Clinical picture and outcome of Serious Adverse Events in the treatment of Onchocerciasis
por: Awadzi, Kwablah
Publicado: (2003)

Possible pathogenic pathways in the adverse clinical events seen following ivermectin administration to onchocerciasis patients.
por: Mackenzie, Charles D, et al.
Publicado: (2003)

Serious Neurological Adverse Events of Ceftriaxone
por: Lacroix, Clémence, et al.
Publicado: (2021)

Evaluation of Lymphatic Filariasis and Onchocerciasis in Three Senegalese Districts Treated for Onchocerciasis with Ivermectin
por: Wilson, Nana O., et al.
Publicado: (2016)

Individual risk of post-ivermectin serious adverse events in subjects infected with Loa loa
por: Chesnais, Cédric B., et al.
Publicado: (2020)

The impact of ivermectin on onchocerciasis in villages co-endemic for lymphatic filariasis in an area of onchocerciasis recrudescence in Burkina Faso
por: Nikièma, Achille S., et al.
Publicado: (2021)

Would ivermectin for malaria control be beneficial in onchocerciasis-endemic regions?
por: Siewe Fodjo, Joseph Nelson, et al.
Publicado: (2019)

Collateral Impact of Community-Directed Treatment with Ivermectin (CDTI) for Onchocerciasis on Parasitological Indicators of Loa loa Infection
por: Nana-Djeunga, Hugues C., et al.
Publicado: (2020)

Adherence to ivermectin is more associated with perceptions of community directed treatment with ivermectin organization than with onchocerciasis beliefs
por: Dissak-Delon, Fanny Nadia, et al.
Publicado: (2017)

Report of a Scientific Working Group on Serious Adverse Events following Mectizan(® ) treatment of onchocerciasis in Loa loa endemic areas
Publicado: (2003)

Compliance with eight years of annual ivermectin treatment of onchocerciasis in Cameroon and Nigeria
por: Brieger, William R, et al.
Publicado: (2011)

Sustainable Control of Onchocerciasis: Ocular Pathology in Onchocerciasis Patients Treated Annually with Ivermectin for 23 Years: A Cohort Study
por: Banla, Méba, et al.
Publicado: (2014)

The geographic distribution of onchocerciasis in the 20 participating countries of the African Programme for Onchocerciasis Control: (1) priority areas for ivermectin treatment
por: Noma, Mounkaila, et al.
Publicado: (2014)

Overview: Report of a Scientific Working Group on Serious Adverse Events following Mectizan(®) treatment of onchocerciasis in Loa loa endemic areas.
por: Duke, Brian OL
Publicado: (2003)

Drawing and interpreting data: Children's impressions of onchocerciasis and community-directed treatment with ivermectin (CDTI) in four onchocerciasis endemic countries in Africa
por: Amuyunzu-Nyamongo, Mary, et al.
Publicado: (2011)

Impact of long-term treatment of onchocerciasis with ivermectin in Ecuador: potential for elimination of infection
por: Vieira, Juan Carlos, et al.
Publicado: (2007)

Primary motives for demand of ivermectin drug in mass distribution programmes to control onchocerciasis
por: Abanobi, Okwuoma, et al.
Publicado: (2011)

Uncertainty Surrounding Projections of the Long-Term Impact of Ivermectin Treatment on Human Onchocerciasis
por: Turner, Hugo C., et al.
Publicado: (2013)

Interruption of Infection Transmission in the Onchocerciasis Focus of Ecuador Leading to the Cessation of Ivermectin Distribution
por: Lovato, Raquel, et al.
Publicado: (2014)

Elimination of African Onchocerciasis: Modeling the Impact of Increasing the Frequency of Ivermectin Mass Treatment
por: Coffeng, Luc E., et al.
Publicado: (2014)

A serious nightmare: psychiatric and neurologic adverse reactions to mefloquine are serious adverse reactions
por: Nevin, Remington L.
Publicado: (2017)

Assessment of microfilarial loads in the skin of onchocerciasis patients after treatment with different regimens of doxycycline plus ivermectin
por: Debrah, Alexander Yaw, et al.
Publicado: (2006)

Comparison of Repeated Doses of Ivermectin Versus Ivermectin Plus Albendazole for the Treatment of Onchocerciasis: A Randomized, Open-label, Clinical Trial
por: Batsa Debrah, Linda, et al.
Publicado: (2020)

Impact of five annual rounds of mass drug administration with ivermectin on onchocerciasis in Sierra Leone
por: Koroma, Joseph B., et al.
Publicado: (2018)

Factors associated with compliance with community directed treatment with ivermectin for onchocerciasis control in Southwestern Ethiopia
por: Yirga, Daniel, et al.
Publicado: (2010)

Impact of Six Years Community Directed Treatment with Ivermectin in the Control of Onchocerciasis, Western Ethiopia
por: Samuel, Abdi, et al.
Publicado: (2016)

Ivermectin Treatment in Patients With Onchocerciasis-Associated Epilepsy: Protocol of a Randomized Clinical Trial
por: Colebunders, Robert, et al.
Publicado: (2017)

Impacts of ivermectin mass drug administration for onchocerciasis on mosquito populations of Ogun state, Nigeria
por: Omitola, Olaitan Olamide, et al.
Publicado: (2021)

Implementation Challenges of Community Directed Treatment with Ivermectin Program for Control of Onchocerciasis in Ulanga, Tanzania
por: Mushi, Vivian
Publicado: (2021)

Status of parasitological indicators and morbidity burden of onchocerciasis after years of successive implementation of mass distribution of ivermectin in selected communities of Yeki and Asosa districts, Ethiopia
por: Gebrezgabiher, Gebremedhin, et al.
Publicado: (2020)

Impact of ivermectin on onchocerciasis transmission: assessing the empirical evidence that repeated ivermectin mass treatments may lead to elimination/eradication in West-Africa
por: Borsboom, Gerard JJM, et al.
Publicado: (2003)

Prevalence of onchocerciasis in the Fundong Health District, Cameroon after 6 years of continuous community-directed treatment with ivermectin
por: Kamga, Henri Lucien Fouamno, et al.
Publicado: (2011)

Why onchocerciasis transmission persists after 15 annual ivermectin mass drug administrations in South-West Cameroon
por: Forrer, Armelle, et al.
Publicado: (2021)

Prevalence of epilepsy in the onchocerciasis endemic middle belt of Ghana after 27 years of mass drug administration with ivermectin
por: Otabil, Kenneth Bentum, et al.
Publicado: (2023)

Serious adverse events and fatal adverse events associated with nivolumab treatment in cancer patients: Nivolumab-related serious/fatal adverse events
por: Zhao, Bin, et al.
Publicado: (2018)

Drug development for the treatment of onchocerciasis: Population pharmacokinetic and adverse events modeling of emodepside
por: Assmus, Frauke, et al.
Publicado: (2022)

Impact of long-term treatment of onchocerciasis with ivermectin in Kaduna State, Nigeria: first evidence of the potential for elimination in the operational area of the African Programme for Onchocerciasis Control
por: Tekle, Afework Hailemariam, et al.
Publicado: (2012)

Cannot write session to /tmp/vufind_sessions/sess_i1u23u54705ov7v099o3u3tp83